Paper29558404
The Roles of Protein Tyrosine Phosphatases in Hepatocellular Carcinoma.
Huang Y and 4 others. Cancers (Basel), 2018. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. The Roles of Protein Tyrosine Phosphatases in Hepatocellular Carcinoma. Papers, record 29558404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29558404
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References175
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21376233 | Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase. | Cell | 2011 | https://conductscience.org/library/papers/21376233 | PubMed |
| 2 | 25003523 | Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma. | Oncotarget | 2014 | https://conductscience.org/library/papers/25003523 | PubMed |
| 3 | 11694501 | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11694501 | PubMed |
| 4 | 5279523 | Mutation and cancer: statistical study of retinoblastoma. | Proc Natl Acad Sci U S A | 1971 | https://conductscience.org/library/papers/5279523 | PubMed |
| 5 | 15263806 | Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. | Pathobiology | 2004 | https://conductscience.org/library/papers/15263806 | PubMed |
| 6 | 24470239 | Functional genomics identified a novel protein tyrosine phosphatase receptor type F-mediated growth inhibition in hepatocarcinogenesis. | Hepatology | 2014 | https://conductscience.org/library/papers/24470239 | PubMed |
| 7 | 9826659 | Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced transformation of rat-1 fibroblasts and promotes differentiation of K562 cells. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9826659 | PubMed |
| 8 | 19833921 | PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. | Science | 2009 | https://conductscience.org/library/papers/19833921 | PubMed |
| 9 | 25553456 | Protein tyrosine phosphatases in pathological process. | Front Biosci (Landmark Ed) | 2015 | https://conductscience.org/library/papers/25553456 | PubMed |
| 10 | 12237861 | Protein tyrosine phosphatase sigma-deficient mice show aberrant cytoarchitecture and structural abnormalities in the central nervous system. | J Neurosci Res | 2002 | https://conductscience.org/library/papers/12237861 | PubMed |
| 11 | 22353262 | Hepatocellular carcinoma. | Lancet | 2012 | https://conductscience.org/library/papers/22353262 | PubMed |
| 12 | 18515860 | Investigation of protein-tyrosine phosphatase 1B function by quantitative proteomics. | Mol Cell Proteomics | 2008 | https://conductscience.org/library/papers/18515860 | PubMed |
| 13 | 20227042 | Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. | Cancer Cell | 2010 | https://conductscience.org/library/papers/20227042 | PubMed |
| 14 | 21213369 | High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma. | Genes Chromosomes Cancer | 2011 | https://conductscience.org/library/papers/21213369 | PubMed |
| 15 | 25322871 | RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells. | Carcinogenesis | 2014 | https://conductscience.org/library/papers/25322871 | PubMed |
| 16 | 25113440 | Mutational and functional analysis of the tumor-suppressor PTPRD in human melanoma. | Hum Mutat | 2014 | https://conductscience.org/library/papers/25113440 | PubMed |
| 17 | 27911713 | Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3. | Biochem Soc Trans | 2016 | https://conductscience.org/library/papers/27911713 | PubMed |
| 18 | 3841511 | Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. | EMBO J | 1985 | https://conductscience.org/library/papers/3841511 | PubMed |
| 19 | 23111978 | Radiotherapy and hepatocellular carcinoma: update and review of the literature. | Eur Rev Med Pharmacol Sci | 2012 | https://conductscience.org/library/papers/23111978 | PubMed |
| 20 | 23848338 | Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3. | Br J Pharmacol | 2013 | https://conductscience.org/library/papers/23848338 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41602129 | Metabolites involvement in the growth and spread of liver cancer. | Liver Res | 2025 | https://conductscience.org/library/papers/41602129 | PubMed |
| 40104216 | Unveiling racial disparities in prostate cancer using an integrative genomic and transcriptomic analysis. | Cell Insight | 2025 | https://conductscience.org/library/papers/40104216 | PubMed |
| 39154757 | Microcystin-LR activates serine/threonine kinases and alters the phosphoproteome in human HepaRG cells. | Toxicon | 2024 | https://conductscience.org/library/papers/39154757 | PubMed |
| 38463290 | Impact of Protein Phosphatase Expressions on the Prognosis of Hepatocellular Carcinoma Patients. | ACS Omega | 2024 | https://conductscience.org/library/papers/38463290 | PubMed |
| 38424416 | Non-receptor Type PTPases and their Role in Controlling Pathways Related to Diabetes and Liver Cancer Signalling. | Curr Pharm Biotechnol | 2025 | https://conductscience.org/library/papers/38424416 | PubMed |
| 38216925 | Downregulation of PTPRT elevates the expression of survivin and promotes the proliferation, migration, and invasion of lung adenocarcinoma. | BMC Cancer | 2024 | https://conductscience.org/library/papers/38216925 | PubMed |
| 37704288 | Setting sail: Maneuvering SHP2 activity and its effects in cancer. | Adv Cancer Res | 2023 | https://conductscience.org/library/papers/37704288 | PubMed |
| 37175550 | Identification of Novel Candidate Genes for Familial Thyroid Cancer by Whole Exome Sequencing. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37175550 | PubMed |
| 36660927 | Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression (Review). | Oncol Rep | 2023 | https://conductscience.org/library/papers/36660927 | PubMed |
| 36248841 | PTPRD/PTPRT mutation as a predictive biomarker of immune checkpoint inhibitors across multiple cancer types. | Front Immunol | 2022 | https://conductscience.org/library/papers/36248841 | PubMed |
| 36193770 | Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling. | Thorac Cancer | 2022 | https://conductscience.org/library/papers/36193770 | PubMed |
| 36092348 | Characterization of somatic mutations and pathway alterations during hepatocellular carcinoma vascular invasion using next-generation sequencing. | J Gastrointest Oncol | 2022 | https://conductscience.org/library/papers/36092348 | PubMed |
| 36077433 | Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077433 | PubMed |
| 36067230 | Multi-omics subtyping of hepatocellular carcinoma patients using a Bayesian network mixture model. | PLoS Comput Biol | 2022 | https://conductscience.org/library/papers/36067230 | PubMed |
| 35991009 | High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma. | Front Public Health | 2022 | https://conductscience.org/library/papers/35991009 | PubMed |
| 35789644 | Association of PTPRT Mutations with Cancer Metastasis in Multiple Cancer Types. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/35789644 | PubMed |
| 35117843 | PTPRO predicts patient prognosis and correlates with immune infiltrates in human clear cell renal cell carcinoma. | Transl Cancer Res | 2020 | https://conductscience.org/library/papers/35117843 | PubMed |
| 35005289 | Treatment of microglia with Anti-PrP monoclonal antibodies induces neuronal apoptosis in vitro. | Heliyon | 2021 | https://conductscience.org/library/papers/35005289 | PubMed |
| 34650968 | Tumor-Derived Exosomal Protein Tyrosine Phosphatase Receptor Type O Polarizes Macrophage to Suppress Breast Tumor Cell Invasion and Migration. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34650968 | PubMed |
| 34353440 | Protein Tyrosine Phosphatases: A new paradigm in an old signaling system? | Adv Cancer Res | 2021 | https://conductscience.org/library/papers/34353440 | PubMed |
Genes74
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29558404
GET https://conductscience.org/api/papers/v1/29558404/references?page=2